Glioblastoma Vulnerability Discovered with Diet

Scientists have uncovered a 'hidden vulnerability' in Glioblastoma, an aggressive form of brain cancer, suggesting that a specialized diet combined with steroid anti-inflammatory drugs could slow tumor growth. The research, published in Science Advances and involving the Cancer Research UK Scotland Institute, found that steroid medications alter how Glioblastoma cells process vitamin B3. This metabolic weakness can be exploited by reducing the amino acid methionine in a patient's diet, thereby depriving Glioblastoma cells of essential growth metabolites. Dr. Saverio Tardito was a key researcher, and Sam Godfrey of Cancer Research UK highlighted the urgent need for such advancements.